Factor | Perrin.Guyomard2020 (40000)

No DOI

AMU Policy Change: Incentive Tools to Reduce AMU of Critically Important Antimicrobials

Turkey | Not Specified

Description

Before (2014) vs after (2016) incentive tools for reducing AMU of critically important antimicrobials, i.e. prohibition on discounts, rebates, reductions (in effect Jan 1 2015). High level resistance (> 1 ug/mL: clinical breakpoint). Caecal sample @ abatt

Resistance Outcomes

Resistance

Microbe

Outcome

Ciprofloxacin
/

Escherichia coli

See: Figure 4 and Section 4.3 (pg. 3, para. 6)	AMR+ (%)	AMR- (%)	Total (n)
2016: AMU reduction incentive tools in place	8.29		182
2014: No AMU reduction incentive tools	9.20		239